内源性GLP-1系统过度激活与革兰阴性脓毒症的早期固有免疫反应相关并受糖尿病调节
该研究在37例成人脓毒症患者(含或不含2型糖尿病,革兰阴性或培养阴性脓毒症,不同严重程度)中,于入院时及2至4天后检测血浆总GLP-1、活性GLP-1、可溶性二肽基肽酶4(sDPP-4)及固有免疫标志物presepsin(sCD14)和降钙素原(PCT)。结果显示,重度而非非重度脓毒症与GLP-1系统反应显著增加相关,且与PCT和器官功能障碍标志物乳酸相关;培养阳性革兰阴性菌而非培养阴性脓毒症诱导GLP-1系统过度激活,与sCD14、PCT和乳酸升高相关;sDPP-4被脓毒症下调,在革兰阴性脓毒症中与sCD14负相关;糖尿病患者GLP-1反应增加但对重度和革兰阴性脓毒症的固有免疫反应显著减弱。作者认为总GLP-1可能是快速诊断革兰阴性脓毒症及其严重程度的新标志物。
要点
- 在37例成人脓毒症患者中,重度脓毒症(而非非重度)与GLP-1系统反应显著增加相关,且与PCT和乳酸相关。
- 培养阳性革兰阴性菌脓毒症(而非培养阴性脓毒症)诱导GLP-1系统过度激活,与sCD14、PCT和乳酸升高相关。
- 脓毒症下调sDPP-4,且在革兰阴性脓毒症中sDPP-4与sCD14负相关。
- 糖尿病患者GLP-1反应增加,但对重度和革兰阴性脓毒症的固有免疫反应显著减弱。
- 作者认为总GLP-1可能是快速诊断革兰阴性脓毒症及其严重程度的新标志物。
适用人群与场景
- 37例成人脓毒症患者,包括有或无2型糖尿病、革兰阴性或培养阴性脓毒症、不同严重程度。
- 入院时及入院后2至4天采集血样。
研究设计与关键结果
- 研究类型为在37例成人脓毒症患者中检测血浆总GLP-1、活性GLP-1、sDPP-4、sCD14和PCT的临床研究。
- 重度脓毒症(而非非重度脓毒症)与GLP-1系统反应显著增加相关,且与PCT和乳酸相关。
- 培养阳性革兰阴性菌脓毒症(而非培养阴性脓毒症)诱导GLP-1系统过度激活,与sCD14、PCT和乳酸升高相关。
- sDPP-4被脓毒症下调,在革兰阴性脓毒症中与sCD14负相关。
- 糖尿病患者GLP-1反应增加,但对重度和革兰阴性脓毒症的固有免疫反应显著减弱。
证据类型、等级与局限
- 证据类型:临床研究(成人脓毒症患者血浆标志物检测)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为总GLP-1可能是快速诊断革兰阴性脓毒症及其严重程度的新标志物。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Culture-positive gram-negative sepsis induces greater magnitude of early innate immunity /inflammatory response compared with culture-negative sepsis. We previously demonstrated increased activation of anti-inflammatory Glucagon Like Peptide-1 (GLP-1) hormone in initial phase of sepsis more pronounced in diabetes patients. However, whether GLP-1 system is hyperactivated during the early innate immune response to gram-negative sepsis and modulated by diabetes remains unknown.
OBJECTIVES: Total and active GLP-1, soluble Dipeptidyl peptidase 4 (sDPP-4) enzyme, and innate immunity markers presepsin (sCD14) and procalcitonin (PCT) in plasma were determined by ELISA on admission and after 2 to 4 days in 37 adult patients with and without type 2 diabetes and gram-negative or culture-negative sepsis of different severity.
RESULTS: Severe but not non-severe sepsis was associated with markedly increased GLP-1 system response, which correlated with PCT and the organ dysfunction marker lactate. Culture-positive gram-negative bacteria but not culture-negative sepsis induced hyper-activation of GLP-1 system, which correlated with increased innate immune markers sCD14, PCT, and lactate. GLP-1 inhibitory enzyme sDPP-4 was down regulated by sepsis and correlated negatively with sCD14 in gram-negative sepsis. Diabetic patients demonstrated increased GLP-1 response but significantly weaker innate immune response to severe and gram-negative sepsis.
CONCLUSIONS: Early stage of gram-negative sepsis is characterized by endogenous GLP-1 system hyperactivity associated with over activation of innate immune response and organ dysfunction, which are modulated by diabetes. Total GLP-1 may be novel marker for rapid diagnosis of gram-negative sepsis and its severity.
参考来源
- Bloch O, Perl SH, Lazarovitch T, et al. Hyper-Activation of Endogenous GLP-1 System to Gram-negative Sepsis Is Associated With Early Innate Immune Response and Modulated by Diabetes. Shock. 2021. PMID: 33079891. doi:10.1097/SHK.0000000000001683
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。